Ozturk Ali, Okan Taha
Ozel Saglik International Hospital, Izmir, Turkey. Email:
Department of Cardiology, Izmir University of Economics, Izmir, Turkey.
Cardiovasc J Afr. 2025 Jun 4;36(1):6-11. doi: 10.5830/CVJA-2024-009. Epub 2025 Apr 30.
Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia in adults worldwide, exerting a substantial impact on health, society and healthcare economics. Despite the current management strategies involving direct-current cardioversion (DCCV) and antiarrhythmic drug therapy, recurrence of AF remains a significant challenge. Brain natriuretic peptide (BNP), a crucial neurohormone, has been associated with AF recurrence; however, existing studies have yielded inconclusive results. Diastolic dysfunction, assessed using echocardiography, has also been implicated in AF recurrence. This study aimed to clarify the relationship between BNP levels, echocardiographic parameters and cardioversion success in patients with persistent AF.
This prospective, observational study enrolled 31 patients with persistent AF. Transthoracic (TTE) and transoesophageal echocardiography, alongside BNP measurements, were performed at various intervals: before cardioversion, 30 minutes post cardioversion and during a One-month follow up. Electrocardiography and TTE were conducted at the one-month mark, categorising patients based on diastolic dysfunction.
Of the 31 patients, 28 successfully converted to sinus rhythm after DCCV. Baseline BNP levels correlated with heart rate and peak E/Em ratio. Patients with early AF recurrence had higher 30-minute BNP levels. Basal BNP levels were not found to be useful in predicting early AF recurrence, whereas BNPlevels at the 30th minute after cardioversion were significantly higher in the group with AF recurrence (318 ± 39.7 vs 153 ± 11.9 pg/ml; = 0.05). Patients with or without mild diastolic dysfunction showed significantly lower BNP levels than those with moderate-to-severe dysfunction.
The study concluded that BNP levels, measured 30 minutes after DCCV, were more indicative of maintaining sinus rhythm than baseline levels. The correlation between baseline BNP and diastolic dysfunction parameters suggests a potential combined assessment for guiding rhythm-control strategies in patients with AF.
心房颤动(AF)是全球成年人中最常见的持续性心律失常,对健康、社会和医疗经济产生重大影响。尽管目前的管理策略包括直流电复律(DCCV)和抗心律失常药物治疗,但AF复发仍然是一个重大挑战。脑钠肽(BNP)作为一种关键的神经激素,与AF复发有关;然而,现有研究结果尚无定论。使用超声心动图评估的舒张功能障碍也与AF复发有关。本研究旨在阐明持续性AF患者的BNP水平、超声心动图参数与复律成功之间的关系。
这项前瞻性观察性研究纳入了31例持续性AF患者。在不同时间点进行经胸(TTE)和经食管超声心动图检查以及BNP测量:复律前、复律后30分钟和1个月随访期间。在1个月时进行心电图和TTE检查,根据舒张功能障碍对患者进行分类。
31例患者中,28例在DCCV后成功转为窦性心律。基线BNP水平与心率和E/Em峰值比值相关。AF早期复发患者的30分钟BNP水平较高。未发现基础BNP水平可用于预测AF早期复发,而AF复发组复律后第30分钟的BNP水平显著高于未复发组(318±39.7 vs 153±11.9 pg/ml;P = 0.05)。有或无轻度舒张功能障碍的患者BNP水平明显低于中重度功能障碍患者。
该研究得出结论,DCCV后30分钟测量的BNP水平比基线水平更能表明窦性心律的维持情况。基线BNP与舒张功能障碍参数之间的相关性表明,在指导AF患者的节律控制策略方面,可能需要进行联合评估。